glp 1 through ro Real-World Evidence for GLP-1 Receptor Agonists Across the CKD Spectrum – AJKD Blog Cardiovascular outcomes in major trials

Older Adults Older adults can use GLP-1 medications safely

Before GLP-1s like Ozempic were approved, earlier trials tested a range of doses and found that lower doses produced some weight loss and blood sugar improvements

Project IDs 322900939 (M03, M05) (to NM), GRK2816 and BI1292/12-1 (to ALB), 520275106 (to the Emmy Noether Research Group), and SFB TRR 219 - 322900939 - M-07 (to FK)

The formula's approach - combining postbiotic gut environment preparation, prebiotic bacterial feeding, and probiotic activation - aligns with published microbiome research principles around SCFA production and L-cell stimulation

Similarly, for kidney health, the FLOW trial demonstrated that semaglutide reduced the risk of severe kidney outcomes, including kidney failure and death, by 24% (HR 0.76, 95% CI 0.660.88)